Get the Stockscreener App
1.705
0.80%
0.01
Bionano Genomics Inc stock is traded at $1.705, with a volume of 37,936.
It is up +0.80% in the last 24 hours and up +1.10% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
See More
Previous Close:
$1.695
Open:
$1.71
24h Volume:
37,936
Relative Volume:
0.05
Market Cap:
$17.39M
Revenue:
$36.12M
Net Income/Loss:
$-232.49M
P/E Ratio:
-0.0959
EPS:
-17.78
Net Cash Flow:
$-126.87M
1W Performance:
-7.64%
1M Performance:
+1.10%
6M Performance:
-53.57%
1Y Performance:
-87.90%
1-Day Range:
$1.70
$1.72
1-Week Range:
$1.59
$1.8716
52-Week Range:
$1.45
$22.80
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
1.7086 | 17.30M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
575.66 | 201.58B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.31 | 55.30B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.44 | 38.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
255.09 | 36.71B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
278.84 | 20.27B | 2.96B | 487.70M | 344.00M | 6.6758 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
Is Bionano Genomics Inc. stock positioned for digital transformationQuarterly Profit Review & Expert Approved Momentum Ideas - Newser
Why Bionano Genomics Inc. stock could outperform in 2025Weekly Profit Recap & Smart Allocation Stock Tips - Newser
How buybacks impact Bionano Genomics Inc. stock valueDay Trade & Real-Time Price Movement Reports - Newser
Bionano Genomics (BNGO) Sees Significant CMS Fee Increase for 20 - GuruFocus
Bionano Genomics (Nasdaq: BNGO) CLFS sets $1853.22 2026 rate for OGM blood cancer code - Stock Titan
Will Bionano Genomics Inc. stock continue dividend increasesTrade Volume Summary & Verified Chart Pattern Trade Signals - Newser
How Bionano Genomics Inc. stock performs in stagflationTrade Volume Summary & Weekly Stock Breakout Alerts - Newser
Bionano Genomics stock hits 52-week low at $0.17 amid market challenges - MSN
What drives Bionano Genomics Inc stock priceStock Buyback Updates & Low Risk Wealth Plans - earlytimes.in
Will Bionano Genomics Inc. stock deliver consistent dividendsPortfolio Value Report & Real-Time Stock Entry Alerts - BỘ NỘI VỤ
HC Wainwright & Co. Maintains Bionano Genomics (BNGO) Buy Recommendation - Nasdaq
Bionano Genomics price target lowered to $7 from $11 at H.C. Wainwright - MSN
Bionano Genomics stock price target lowered to $7 at H.C. Wainwright - Investing.com Canada
Bionano Genomics Inc. (BNGO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
BNGO: HC Wainwright & Co. Lowers Price Target Despite Buy Rating - GuruFocus
Baidu To Rally More Than 69%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
CapEx per share of Bionano Genomics, Inc. – LSE:0A4K - TradingView
Bionano Genomics stock rises on Q1 revenue beat - MSN
Will Bionano Genomics Inc. stock maintain growth story2025 Support & Resistance & Low Risk Profit Maximizing Plans - newser.com
How institutional buying supports Bionano Genomics Inc. stockTrade Signal Summary & Daily Technical Forecast Reports - newser.com
Full technical analysis of Bionano Genomics Inc. stockWeekly Trading Summary & High Accuracy Trade Alerts - newser.com
Combining price and volume data for Bionano Genomics Inc.Weekly Risk Summary & Precise Swing Trade Alerts - newser.com
Using flow based indicators on Bionano Genomics Inc.Rate Hike & AI Powered Buy and Sell Recommendations - newser.com
Risk adjusted return profile for Bionano Genomics Inc. analyzedJobs Report & Free Accurate Trade Setup Notifications - newser.com
What moving averages say about Bionano Genomics Inc.July 2025 Price Swings & Reliable Price Breakout Signals - newser.com
Measuring Bionano Genomics Inc.’s beta against major indicesTrade Risk Report & Reliable Entry Point Alerts - newser.com
What to do if you’re stuck in Bionano Genomics Inc.Quarterly Profit Report & Real-Time Volume Analysis Alerts - newser.com
Certain Warrants of Bionano Genomics, Inc. are subject to a Lock-Up Agreement Ending on 17-NOV-2025. - MarketScreener
Certain Stock Options of Bionano Genomics, Inc. are subject to a Lock-Up Agreement Ending on 17-NOV-2025. - MarketScreener
4,755,265 Common Stock of Bionano Genomics, Inc. are subject to a Lock-Up Agreement Ending on 17-NOV-2025. - MarketScreener
How to build a custom watchlist for Bionano Genomics Inc.July 2025 Fed Impact & Daily Market Momentum Tracking - newser.com
Is Bionano Genomics Inc. stock entering bullish territory2025 Trading Volume Trends & Real-Time Market Trend Scan - newser.com
Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus - MSN
Building trade automation scripts for Bionano Genomics Inc.Quarterly Investment Review & Weekly Hot Stock Watchlists - newser.com
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):